Literature DB >> 18815868

Serovar-specific immune responses to peptides of variable regions of Chlamydia trachomatis major outer membrane protein in serovar D-infected women.

Pragya Srivastava1, Rishein Gupta, Hem Chandra Jha, Rajneesh Jha, Apurb Rashmi Bhengraj, Sudha Salhan, Aruna Mittal.   

Abstract

The role of major outer membrane protein (MOMP) variable regions in the interaction of chlamydiae and host cells has been evaluated and their role in neutralization of antibodies has been clearly demonstrated. There are also studies that delineate the contribution of these regions to the cell-mediated immune response of the host and suggest that serovar E elicits serovar-specific immune responses in infected humans. However, further studies with other serovars are required to confirm these findings and to elucidate the role and importance of serovar-specific responses of variable regions of MOMP in other serovars. We, therefore, performed a detailed analysis of the humoral and cellular immune responses against the serovar D-specific variable segments (VS) of MOMP in women infected with Chlamydia trachomatis. We found that VS4 elicits significantly higher responses (both humoral and cellular) than other VS peptides (VS1, VS2 and VS3). VS4 elicited significantly higher (P < 0.0001) proliferative responses, interferon-gamma levels (P < 0.0001) as well as higher prevalence (P < 0.0001) of IgG antibodies against VS4 in serovar D-infected patients as compared to patients infected with other serovars, suggesting its role in serovar-specific immune responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18815868     DOI: 10.1007/s10238-008-0004-2

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  49 in total

1.  T-cell epitopes in variable segments of Chlamydia trachomatis major outer membrane protein elicit serovar-specific immune responses in infected humans.

Authors:  L Ortiz; M Angevine; S K Kim; D Watkins; R DeMars
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

Review 2.  Chlamydia vaccines: strategies and status.

Authors:  Joseph U Igietseme; Carolyn M Black; Harlan D Caldwell
Journal:  BioDrugs       Date:  2002       Impact factor: 5.807

Review 3.  How, and how efficiently, can we treat Chlamydia trachomatis infections in women?

Authors:  Secondo Guaschino; Giuseppe Ricci
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2002-12       Impact factor: 5.237

4.  Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes.

Authors:  W Baehr; Y X Zhang; T Joseph; H Su; F E Nano; K D Everett; H D Caldwell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

5.  Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge.

Authors:  S Pal; I Theodor; E M Peterson; L M de la Maza
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

6.  Different humoral immune response to Chlamydia trachomatis major outer membrane protein variable domains I and IV in Chlamydia-infected patients with or without reactive arthritis.

Authors:  S Bas; C Scieux; T L Vischer
Journal:  Arthritis Rheum       Date:  1999-05

7.  Does inhibition of tumor necrosis factor alpha affect chlamydial genital tract infection in mice and guinea pigs?

Authors:  T Darville; C W Andrews; R G Rank
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

8.  Immunoepidemiologic profile of Chlamydia trachomatis infection: importance of heat-shock protein 60 and interferon- gamma.

Authors:  Craig R Cohen; Kasra M Koochesfahani; Amalia S Meier; Caixia Shen; Karuna Karunakaran; Beartrice Ondondo; Teresa Kinyari; Nelly R Mugo; Rosemary Nguti; Robert C Brunham
Journal:  J Infect Dis       Date:  2005-07-07       Impact factor: 5.226

9.  Predominance of Chlamydia trachomatis serovars associated with urogenital infections in females in New Delhi, India.

Authors:  Vineeta Singh; Sudha Salhan; B C Das; A Mittal
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

10.  Chlamydia trachomatis infection in asymptomatic men.

Authors:  D Scott LaMontagne; David N Fine; Jeanne M Marrazzo
Journal:  Am J Prev Med       Date:  2003-01       Impact factor: 5.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.